Previous close | 1.4900 |
Open | 1.5300 |
Bid | 1.4500 x 100 |
Ask | 1.5200 x 100 |
Day's range | 1.4500 - 1.5400 |
52-week range | 0.8160 - 2.2900 |
Volume | |
Avg. volume | 142,786 |
Market cap | 98.163M |
Beta (5Y monthly) | 0.50 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Completion of Phase 3 Trial Enrollment Marks a Milestone for IOBT's Lead Cancer Vaccine
Key Insights IO Biotech's significant private equity firms ownership suggests that the key decisions are influenced by...
We can readily understand why investors are attracted to unprofitable companies. For example, although...